Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Upstream Bio, Inc.
- Blueprint Medicines Corp
Updated Jul 16, 2026
Beckman Daniella has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $127K.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-05 | TNGX | Tango Therapeutics, Inc. | S — Open-market sale | 113 | $12.90 | $1K |
| 2026-02-05 | TNGX | Tango Therapeutics, Inc. | S — Open-market sale | 10.2K | $12.26 | $125K |
| 2026-02-05 | TNGX | Tango Therapeutics, Inc. | A — Grant or award | 44.3K | $0.00 | |
| 2025-07-17 | BPMC | Blueprint Medicines Corp | J — Other acquisition / disposition | 10.8K | — | |
| 2025-07-17 | BPMC | Blueprint Medicines Corp | D — Derivative transaction | 3.9K | — |
Beckman Daniella is a corporate insider — currently tracked as Insider of Vor Biopharma Inc. (VOR). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($127K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Beckman Daniella profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.